MarketPulse

micro reactors

2 articles
The Motley FoolThe Motley Fool··Steven Porrello

Oklo's $13B Valuation Bet: Assessing the Risk-Reward of Investing in Pre-Revenue Nuclear Tech

Oklo, valued at $13B with zero revenue and $100M annual cash burn, represents extreme risk-reward. Meta backing and 14 GW backlog offer upside, but regulatory approval and commercialization remain unproven.
OKLOMETAnuclear energydata centers
The Motley FoolThe Motley Fool··Courtney Carlsen

Nano Nuclear Energy Stock Drops 60% Amid Regulatory Timeline Uncertainty

Nano Nuclear Energy stock plunged 60% due to regulatory delays and extended timeline uncertainty. The pre-revenue company won't commercialize its micro reactor technology until the 2030s.
NNEnuclear energyregulatory approval